Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Das Thema chronische Unterbauch- und Viszeralschmerzen wird im Live-Webinar am 7. Mai von 17.30 bis 19 Uhr aus internistischer, gynäkologischer und psychologisch-neurowissenschaftlicher Perspektive beleuchtet. Besprochen werden krankheitsbedingte Ursachen, Mechanismen der kognitiven Schmerzmodulation sowie mögliche Therapieoptionen. Die Fortbildung ist mit 2 CME-Punkten zertifiziert. Melden Sie sich jetzt an!
Erweiterte Suche
Anmelden
nach oben
Immunologic Research
Erschienen in: Immunologic Research 2/2017

22.02.2017 | Novel Aspects in Lupus, 2017

Topics on vitamin D in systemic lupus erythematosus: analysis of evidence and critical literature review

verfasst von: António Marinho, Mariana Taveira, Carlos Vasconcelos

Erschienen in: Immunologic Research | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multiorgan inflammation, linked to the loss of immune tolerance to self-antigens and the production of a diversity of autoantibodies. The phenotype and progression of SLE have been linked to a combination of environmental, genetic, and hormonal factors. One such environmental factor is vitamin D, a vital hormone with well-established effects on mineral metabolism, skeletal health, and effects on cardiovascular system. The purpose of this article is to make the analysis of evidence and literature review of the pleomorphic effects of Vitamin D in SLE. The article is structured in topics of interest based in the authors’ opinion and summarizes the evidence of studies and trials of vitamin D in SLE
https://static-content.springer.com/image/art%3A10.1007%2Fs12026-017-8903-5/MediaObjects/12026_2017_8903_Figa_HTML.jpg
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Askanase A, Shum K, Mitnick H. Systemic lupus erythematosus: an overview. Soc Work Health Care. 2012;51(7):576–86.CrossRefPubMed
3.
Kunz M. Lupus erythematosus. Part I: epidemiology, genetics and immunology. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG. 2013;11(8):709–19.PubMed
4.
5.
Perricone C, Agmon-Levin N, Colafrancesco S, Shoenfeld Y. Vitamins and systemic lupus erythematosus: to D or not to D. Expert Rev Clin Immunol. 2013;9(5):397–9.CrossRefPubMed
6.
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482–96.CrossRefPubMed
7.
Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One. 2010;5(2):e9193.CrossRefPubMedPubMedCentral
8.
Borella E, Nesher G, Israeli E, Shoenfeld Y. Vitamin D: a new anti-infective agent? Ann N Y Acad Sci. 2014;1317:76–83.CrossRefPubMed
9.
Bizzaro G, Shoenfeld Y. Vitamin D: a panacea for autoimmune diseases? Can J Physiol Pharmacol. 2015;93(5):395–7.CrossRefPubMed
10.
Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. Changes in vitamin D levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken). 2010;62(8):1160–5.CrossRef
11.
Kamen DL. Vitamin D in lupus - new kid on the block? Bull NYU Hosp Joint Dis. 2010;68(3):218–22.
12.
Vinh Quoc Luong K, Nguyen LT. The beneficial role of vitamin D in systemic lupus erythematosus (SLE). Clin Rheumatol. 2012;31(10):1423–35.CrossRefPubMed
13.
Cocco E, Meloni A, Murru MR, Corongiu D, Tranquilli S, Fadda E, et al. Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles. PLoS One. 2012;7(7):e41678.CrossRefPubMedPubMedCentral
14.
Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA et al.. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009;5(2).
15.
Binkley N, Ramamurthy R, Krueger D, et al. Endocrinol Metab Clin North Am Endocrinol Metab Clin North Am. 2010;39(2):287. contentsCrossRefPubMed
16.
Bettencourt A, Carvalho C, Leal B, Brás S, Lopes D Martins da Silva A et al. The protective role of HLA-DRB1 (∗) 13 in autoimmune diseases. J Immunol Res. 2015;2015.
17.
Xiong J, He Z, Zeng X, Zhang Y, Hu Z. Association of vitamin D receptor gene polymorphisms with systemic lupus erythematosus: a meta-analysis. Clin Exp Rheumatol. 2014;32(2):174–81.PubMed
18.
19.
Holick MF. Vitamin D: extraskeletal health. Rheum Dis Clin N Am. 2012;38(1):141–60.CrossRef
20.
Kemp MG, Lindsey-Boltz LA, Sancar A. UV light potentiates STING (stimulator of interferon genes)-dependent innate immune signaling through deregulation of ULK1 (Unc51-like kinase 1). J Biol Chem. 2015;290(19):12184–94.CrossRefPubMedPubMedCentral
21.
Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12:127–36.CrossRefPubMed
22.
Kang SW, Kim SH, Lee N, Lee WW, Hwang KA, Shin MS, et al. 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. J Immunol. 2012;188(11):5276–82.CrossRefPubMedPubMedCentral
23.
Lerman MA, Burnham J, Behrens E. 1, 25 Dihydroxyvitamin D3 limits monocyte maturation in lupus sera. Lupus. 2011;20(7):749–53.CrossRefPubMed
24.
Wu HJ, Lo Y, Luk D, Lau CS, Lu L, Mok MY. Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function. Clin Immunol. 2015;156(1):43–57.CrossRefPubMed
25.
Aranow C, Kamen DL, Dall'Era M, Massarotti EM, Mackay MC, Koumpouras F, et al. Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67(7):1848–57.CrossRefPubMedPubMedCentral
26.
Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther. 2012;14:R221.CrossRefPubMedPubMedCentral
27.
Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol. 2015;45(2):344–55.CrossRefPubMed
28.
Souza VA, Bastos MG, Fernandes NMS, Mansur HN, Raposo NRB, Souza DNK, et al. Association of hypovitaminosis D with systemic lupus erythematosus and inflammation. Jornal Brasileiro Nefrologia. 2014;36(4):430–6.
29.
Banica LM, Besliu AN, Pistol GC, Stavaru C, Vlad V, Predeteanu D et al. Dysregulation of anergy-related factors involved in regulatory T cells defects in systemic lupus erythematosus patients: rapamycin and vitamin D efficacy in restoring regulatory T cells. Int J Rheum Dis. 2014 28.
30.
Piantoni S, Andreoli L, Scarsi M, Zanola A, Dall'Ara F, Pizzorni C, et al. Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D. Lupus. 2015;24(4–5):490–8.CrossRefPubMed
31.
Wahono CS, Rusmini H, Soelistyoningsih D, Hakim R, Handono K, Endharti AT, et al. Effects of 1,25(OH)2D3 in immune response regulation of systemic lupus erithematosus (SLE) patient with hypovitamin D. Int J Clin Exp Med. 2014;7(1):22–31.PubMedPubMedCentral
32.
Drozdenko G, Heine G, Worm M. Oral vitamin D increases the frequencies of CD38+ human B cells and ameliorates IL-17-producing T cells. Exp Dermatol. 2014;23(2):107–12.CrossRefPubMed
33.
Marinho A, Carvalho C, Boleixa D, Bettencourt A, Leal B, Guimarães J et al. Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohort. Immunol Res. 2016 16.
34.
Vukić M, Neme A, Seuter S, Saksa N, de Mello VD, Nurmi T, et al. Relevance of vitamin D receptor target genes for monitoring the vitamin D responsiveness of primary human cells. PLoS One. 2015;13:10(4).
35.
Adnan N, Kiani, Fang H, Magder LS, Petri M. Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology (Oxford). 2013;52(11):2071–6.CrossRef
36.
Robinson AB, Tangpricha V, Yow E, Gurion R, Schanberg LA, McComsey GA, for the APPLE investigators. Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy. Lupus Science & Medicine 2014; 1.
37.
Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg LE; APPLE Investigators. Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med. 2014; 1 (1).
38.
Lertratanakul A, et al. 25-Hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care Res (Hoboken). 2014;66(8):1167–76.CrossRef
39.
Reynolds JA, Haque S, Berry JL, Pemberton P, Teh LA, Ho P, et al. 25-hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012;51(3):544–51.CrossRef
40.
Sabio JM, Vargas-Hitos JA, Martinez-Bordonado J, Navarrete-Navarrete N, Díaz-Chamorro A, Olvera-Porcel C, et al. Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus. Lupus. 2015;24(2):155–63.CrossRefPubMed
41.
Reynolds JA, Haque S, Williamson K, Ray DW, Alexander MY, Bruce IN. Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus. Sci Rep. 2016;6:22341.CrossRefPubMedPubMedCentral
42.
Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol. 2013;40(3):265–72.CrossRefPubMed
43.
Hollan I, Dessein PH, Ronda N, Wasko MC, Svenungsson E, Agewall S, et al. Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmun Rev. 2015;14(10):952–69.CrossRefPubMed
44.
Irfete S. Fetahu, Hobaus J., Kallay E. Vitamin D and the epigenome. Frontiers in phisiology .2014; 5:164.
45.
Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29(9):3511–36.PubMed
46.
47.
Rolf L, Damoiseaux J, Hupperts R, Huitinga I, Smolders J.Network of nuclear receptor ligands in multiple sclerosis: Common pathways and interactions of sex-steroids, corticosteroids and vitamin D<sub>3</sub>-derived molecules. Autoimmun Rev. 2016.
48.
Tuoresmäki P, Väisänen S, Neme A, Heikkinen S, Carlberg C. Patterns of genome-wide VDR locations. PLoS One. 2014 30; 9(4).
49.
Arash HN, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One. 2013;8(3):e58725.CrossRef
50.
51.
Moray J, Campbell. Vitamin D and the RNA transcriptome: more than mRNA regulation. Front Physiol. 2014;5:181.
52.
Carvalho C, Marinho A, Leal B, Bettencourt A, Boleixa D, Almeida I, et al. Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus. 2015;24(8):846–53.CrossRefPubMed
53.
Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, et al. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J Clin Endocrinol Metab. 2014;99(10):E2133–7.CrossRefPubMedPubMedCentral
54.
Monticielo OA, Brenol JC, Chies JA, Longo MG, Rucatti GG, Scalco R, Xavier RM. The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus. 2012;21(1):43–52.CrossRefPubMed
55.
Watad A, Neumann SG, Soriano A, Amital H, Shoenfeld Y. Vitamin D and systemic lupus erythematosus: myth or reality? Isr Med Assoc J. 2016;18(3–4):177–82.PubMed
56.
Azrielant S, Shoenfeld Y. Eppur Si Muove: vitamin D is essential in preventing and modulating SLE. Lupus. 2016;25(6):563–72.CrossRefPubMed
57.
Birmingham DJ, Hebert LA, Song H, Noonan WT, Rovin BH, Nagaraja HN, Yu CY. Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus. 2012;21(8):10.CrossRefPubMedCentral
58.
Schoindreet Y al. Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up. Lupus Sci Med. 2014; 1(1).
59.
Roy S, Shrinivas K, Bagchi B. A stochastic chemical dynamic approach to correlate autoimmunity and optimal vitamin D range. PLoS One. 2014 Jun27:9(6).
60.
Fattizzo B, Zaninoni A, Giannotta JA, Binda F, Cortelezzi A, Barcellini W. Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review. Autoimmun Rev. 2016;15(7):770–5.CrossRefPubMed
61.
Agmon-Levin N, Kivity S, Tzioufas AG, López Hoyos M, Rozman B, Efes I, et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. J Autoimmun. 2012;39(3):234–9.CrossRefPubMed
62.
Muscogiuri G, Tirabassi G, Bizzaro G, Orio F, Paschou SA, Vryonidou A, et al. Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr. 2015;69(3):291–6.CrossRefPubMed
63.
Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality - a review of recent evidence. Autoimmun Rev. 2013;12(10):976–89.CrossRefPubMed
Metadaten
Titel
Topics on vitamin D in systemic lupus erythematosus: analysis of evidence and critical literature review
verfasst von
António Marinho
Mariana Taveira
Carlos Vasconcelos
Publikationsdatum
22.02.2017
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 2/2017
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-017-8903-5

Weitere Artikel der Ausgabe 2/2017

Immunologic Research 2/2017 Zur Ausgabe

Novel Aspects in Lupus, 2017

Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study

Novel Aspects in Lupus, 2017

Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features

Novel Aspects in Lupus, 2017

Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature

Novel Aspects in Lupus, 2017

Chronic hepatitis C viral infection among SLE patients: the significance of coexistence

Novel Aspects in Lupus, 2017

Prolactin has a pathogenic role in systemic lupus erythematosus

Novel Aspects in Lupus, 2017

HPV and systemic lupus erythematosus: a mosaic of potential crossreactions

Neu im Fachgebiet HNO

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise